Andrew J. Nowalk

Andrew J. Nowalk

Auto-generated profile, based on publicly available information

Andrew J. Nowalk

Division of Pediatric Infectious Diseases, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1997 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
CBChristopher M. Bruns
Christopher M. Bruns
ANAndrew J. Nowalk
Andrew J. Nowalk
AAAndrew S. Arvai
Andrew S. Arvai
MMMichele A. McTigue
Michele A. McTigue
KVKevin G. Vaughan
Kevin G. Vaughan
DMDuncan E. McRee
Duncan E. McRee

17 May 2018 in Pediatrics
Verified
Journal Article
Closed access
PDF file
CSCasey G. Sommerfeld
Casey G. Sommerfeld
DWDaniel J. Weiner
Daniel J. Weiner
ANAndrew Nowalk
Andrew Nowalk
ALAllyson Larkin
Allyson Larkin
Electronic cigarette (e-cigarette) use, or “vaping,” is gaining widespread popularity as an alternative to conventional cigarettes among adolescents. Little is known of the health risks of e-cigarette use, especially in children and adolescents. We present a Case Report of a previously healthy 18-year-old woman who presented with dyspnea, cough, and pleuritic chest pain after e-cigarette use. She developed respiratory failure with hypoxia and was intubated, and ultimately met diagnostic criteria for acute respiratory distress syndrome. Chest tubes were placed to drain worsening pleural effusions. Computed tomography of the chest revealed dependent opacities in both lung bases, superimposed smooth interlobular septal thickening, and pleural effusions. Bronchoalveolar lavage revealed cellular debris and reactive mononuclear cells, and cell counts were remarkable for elevated mononuclear cells and eosinophilia. After the results of a workup for an infectious etiology came back negative, the patient was diagnosed with hypersensitivity pneumonitis and intravenous methylprednisolone therapy was initiated. After this the patient rapidly improved, was weaned off vasopressor support, and was extubated. This is the first reported case of hypersensitivity pneumonitis and acute respiratory distress syndrome as a risk of e-cigarette use in an adolescent, and it should prompt pediatricians to discuss the potential harms of vaping with their patients. Hypersensitivity pneumonitis, lipid pneumonia, and eosinophilic pneumonia should be included in the differential diagnosis of patients who exhibit respiratory symptoms after the use of an e-cigarette.

1 July 2006 in Infection and Immunity
Verified
Journal Article
Closed access
ANAndrew J. Nowalk
Andrew J. Nowalk
RGRobert D. Gilmore
Robert D. Gilmore
JCJames A. Carroll
James A. Carroll
Lyme disease, a global health concern, is caused by infection withBorrelia burgdorferi,B. afzelii, orB. garinii. The spirochete responsible for the disease in the United States isB. burgdorferiand is spread by the bite of an infectedIxodestick. We utilized multiple two-dimensional gel techniques combined with proteomics to reveal the full humoral immune response of mice and Lyme patients to membrane-associated proteins isolated fromBorrelia burgdorferi. Our studies indicated that a subset of immunogenic membrane-associated proteins (some new and some previously identified) was recognized by mice experimentally infected withBorrelia burgdorferieither by low-dose needle inoculation or by tick infestation. Moreover, the majority of these immunogenic membrane-associated proteins were recognized by sera from patients diagnosed with early-disseminated Lyme disease. These included RevA, ErpA, ErpP, DbpA, BmpA, FtsZ, ErpB, LA7, OppA I, OppA II, OppA IV, FlhF, BBA64, BBA66, and BB0323. Some immunogens (i.e., BBI36/38) were more reactive with sera from mice than Lyme patients, while additional membrane proteins (i.e., FlaB, P66, LA7, and Hsp90) were recognized more strongly with sera from patients diagnosed with early-localized, early-disseminated, or late (chronic)-stage Lyme disease. We were able to examine the humoral response in Lyme patients in a temporal fashion and to identify the majority of immunoreactive proteins as the disease progresses from early to late stages. This serologic proteome analysis enabled the identification of novel membrane-associated proteins that may serve as new diagnostic markers and, more importantly, as second-generation vaccine candidates for protection against Lyme disease.

30 November 2001 in Biochemistry
Verified
Journal Article
Closed access
CBChristopher M. Bruns
Christopher M. Bruns
DADamon S. Anderson
Damon S. Anderson
KVKevin G. Vaughan
Kevin G. Vaughan
PWPatricia A.M. Williams
Patricia A.M. Williams
ANAndrew J. Nowalk
Andrew J. Nowalk
TMTimothy A. Mietzner
Timothy A. Mietzner

21 July 2017 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
ABAnna Bowen
Anna Bowen
HWHarold C. Wiesenfeld
Harold C. Wiesenfeld
JKJennifer L. Kloesz
Jennifer L. Kloesz
APA. William Pasculle
A. William Pasculle
ANAndrew J. Nowalk
Andrew J. Nowalk
CTCheryl L. Tarr
Cheryl L. Tarr

22 March 2006 in Proteomics
Verified
Journal Article
Closed access
PDF file
ANAndrew J. Nowalk
Andrew J. Nowalk
CNChristi Nolder
Christi Nolder
DCDawn R. Clifton
Dawn R. Clifton
JCJames A. Carroll
James A. Carroll